Blood Marrow Transplant Tandem Meetings

The Medical Directors Conference this year provides an up-to-the-minute look at how data on related and unrelated allogeneic hematopoietic stem cell transplant outcomes are being collected and analyzed for center-specific reports – a requirement of the Stem Cell Therapeutic and Research Act of 2005. The BMT community is responding to the new federal law with the Stem Cell Transplant Outcomes Database (SCTOD).

This session will feature a panel discussion of key questions likely to be faced by program directors. It is designed to be interactive and questions/comments will be encouraged.

Questions to be addressed include: • When will my center’s data be analyzed? • What outcomes will be measured to assess my center’s performance? • How will center-specific reports be made available to me and to the public? • Will my center’s outcomes be adjusted for patient volume, participation in clinical trials or other patient and treatment variables? • Will pediatric patient outcomes be handled differently than adult patient outcomes? • What should I do if an outcome for my center falls outside of norms? • Are steps being taken to anticipate and prevent unintended consequences of center-specific reporting?

Although specifically designed for BMT center medical directors, the conference is open to administrative directors and all BMT Tandem Meetings registrants.